Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS
J. Clin. Invest. Luisa M. Villar, et al. 115:187 doi:10.1172/JCI22833 [Go to this article.]

Figure 2
B cell subsets in MS. The percentage of CD19⁺CD5⁺ cells is higher in CSF of M+ MS patients when compared with M– MS patients (P < 0.0001). There are no significant differences in CSF CD19⁺CD5^– cells between the 2 groups of patients.